Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
second_navbar.gif (585 bytes)
 
Research

Imported Lassa Fever in Germany: 
Molecular Characterization of a New Lassa Virus Strain

Stephan Günther, Petra Emmerich, Thomas Laue, Olaf Kühle, Marcel Asper, Annegret Jung, Thomas Grewing, Jan ter Meulen, and Herbert Schmitz
Bernhard-Nocht-Institut für Tropenmedizin, Hamburg, Germany


Back to article

Figure 3. Reverse transcription (RT) and polymerase chain reaction (PCR) amplification of full-length S RNA. (A) Position of the RT and PCR primers at the termini of S RNA. The stem-loop structure in the intergenic region is schematically shown. (B) Amplified S RNA of Lassa Josiah and LCMV Armstrong virus separated in ethidium bromide-stained agarose gel. S RNA was isolated from supernatant of infected cells, and PCR was done with primers PCR2-4. (C) S RNA of Lassa AV was amplified in two RT-PCRs (a and b) and separated in ethidium bromide-stained agarose gel. RNA was isolated from serum, and PCR was performed with primers PCR2-4. Quantification of Lassa virus RNA in the specimen by endpoint titration with the 340-bp PCR assay showed >106 S RNA molecules/mL serum.
 

Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed August 1, 2000

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention